Shanghai Junshi Biosciences Co Ltd Class H 01877
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover 01877, but with our powerful screener, you can find
stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 10.03
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.65%
Company Profile
Shanghai Junshi Biosciences Co Ltd is a China-based biotechnology companyy with all-round capabilities in innovative drug discovery and development, clinical research on a global scale, large-scale production capacity to commercialization on the full industry chain. Aiming to develop first-in-class or bestin-class drugs by way of original innovation and co-development. Companies operations are located in the PRC and the USA.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,532
- Website
- https://www.junshipharma.com
Comparables
Valuation
|
Metric
|
01877
|
300122
|
688319
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 13.47 | 447.06 |
Price/Book Value | 2.53 | 2.53 | 4.90 |
Price/Sales | 10.03 | 1.71 | 8.82 |
Price/Cash Flow | — | 11.11 | 555.27 |
Price/Earnings
01877
300122
688319
Financial Strength
|
Metric
|
01877
|
300122
|
688319
|
|---|---|---|---|
Quick Ratio | 1.70 | 1.37 | 1.63 |
Current Ratio | 2.07 | 2.07 | 1.83 |
Interest Coverage | −52.22 | 76.85 | −3.55 |
Quick Ratio
01877
300122
688319
Profitability
|
Metric
|
01877
|
300122
|
688319
|
|---|---|---|---|
Return on Assets (Normalized) | −18.12% | 11.64% | −3.07% |
Return on Equity (Normalized) | −28.82% | 19.62% | −5.38% |
Return on Invested Capital (Normalized) | −21.99% | 17.67% | −3.43% |
Return on Assets
01877
300122
688319
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Jrwylnsfj | Sjppk | $512.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Nrphhtwt | Ykzllb | $117.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Dlphmsz | Bbvvkm | $111.6 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Gcwykzjh | Zfskf | $34.4 Bil | |||
| argenx SE ADR
ARGX
| Nznphhgb | Hndm | $31.7 Bil | |||
| BioNTech SE ADR
BNTX
| Ttcvkfln | Mrw | $29.2 Bil | |||
| Moderna Inc
MRNA
| Qxvzvwdp | Zyjjf | $23.1 Bil | |||
| United Therapeutics Corp
UTHR
| Mgfwgychx | Njl | $15.8 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Jbjsjrhkc | Jwxfty | $13.2 Bil | |||
| Incyte Corp
INCY
| Qsgqczkn | Xkhqlps | $13.0 Bil |
United States